Mesoblast Limited
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $57.0M | $549.3M | $129.3M |
| FY2021 | $41.0M | $581.4M | $136.9M |
| FY2022 | $91.6M | $497.0M | $60.4M |
| FY2023 | $102.8M | $501.8M | $71.3M |
| FY2024 | $100.5M | $480.4M | $63.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $57.0M | $549.3M | $129.3M |
| FY2021 | $41.0M | $581.4M | $136.9M |
| FY2022 | $91.6M | $497.0M | $60.4M |
| FY2023 | $102.8M | $501.8M | $71.3M |
| FY2024 | $100.5M | $480.4M | $63.0M |